Drug-induced fulminant hepatic failure in pregnancy

Document Type

Article

Publication Title

Obstetric medicine

Abstract

Liver disease in pregnancy can be classified as predating, co-incidental or unique to pregnancy. Medications are often overlooked as a significant cause of liver disease. We present the case of a 39-year-old patient who presented at 20 weeks with jaundice, elevated liver enzymes, and abnormal liver function progressing eventually to fulminant hepatic failure. The patient was on methyldopa and labetalol from 12 weeks' gestational age. Liver biopsy was consistent with drug-induced liver injury. Both methyldopa and labetalol have been associated with hepatotoxicity including liver failure. This case highlights the importance of including medications as a cause of liver failure in pregnant patients.

First Page

190

Last Page

2

DOI

10.1177/1753495X15598909

Publication Date

12-1-2015

Identifier

27512479 (pubmed); PMC4935052 (pmc); 10.1177/1753495X15598909 (doi); 10.1177_1753495X15598909 (pii)

This document is currently not available here.

Share

COinS